If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 14.98% on an annualized basis producing an average annual return of 26.94%. Currently, Veeva Systems has a market capitalization of $45.41 billion.
Veeva Systems ( VEEV ) Exceeds Market Returns: Some Facts to Consider
Veeva Systems (VEEV) concluded the recent trading session at $279.18, signifying a +1.36% move from its prior day's close.
2 Top Stocks to Invest $1,000 in Right Now
These stocks continue to beat expectations.
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
VEEV's strong first quarter, product innovations and strategic deals drive growth prospects despite rising costs.
Evolent Health ( EVH ) Reports Q2 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -211.11% and -2.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems ( VEEV ) Declines More Than Market: Some Information for Investors
Veeva Systems (VEEV) closed at $279.76 in the latest trading session, marking a -1.02% move from the prior day.
Veeva Systems Inc. ( VEEV ) Is a Trending Stock: Facts to Know Before Betting on It
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Schrodinger, Inc. ( SDGR ) Reports Q2 Loss, Beats Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of +28.92% and +5.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Veeva ( VEEV ) Upgraded to Buy: What Does It Mean for the Stock?
Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Nuveen ESG Mid-Cap Growth ETF ( NUMG ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Veeva Systems ( VEEV ) Stock Moves -1.09%: What You Should Know
In the closing of the recent trading day, Veeva Systems (VEEV) stood at $281.11, denoting a -1.09% move from the preceding trading day.
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
VEEV leans on Vault R&D for growth as AI-native rivals rise, testing its edge in clinical and regulatory innovation.
Here's Why Veeva Systems ( VEEV ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wall Street Analysts See Veeva ( VEEV ) as a Buy: Should You Invest?
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
OPRX's subscription shift, DAAP platform, and HCP-DTC reach suggest a moat is forming-but is it built to last?
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veeva Systems Inc. ( VEEV ) Hits Fresh High: Is There Still Room to Run?
Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
Edwards Lifesciences posts a second-quarter 2025 earnings and revenue beat, with strong growth in TAVR and TMTT segments despite margin pressure.
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 15.19% on an annualized basis producing an average annual return of 26.84%. Currently, Veeva Systems has a market capitalization of $47.60 billion.
Veeva Systems ( VEEV ) Beats Stock Market Upswing: What Investors Need to Know
Veeva Systems (VEEV) reached $291.25 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
Investors Heavily Search Veeva Systems Inc. ( VEEV ) : Here is What You Need to Know
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.
Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up
BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market
TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises
DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.
Veeva Systems ( VEEV ) Stock Sinks As Market Gains: Here's Why
Veeva Systems (VEEV) reached $276.46 at the closing of the latest trading day, reflecting a -2.13% change compared to its last close.
Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat
ABT beats on Q2 earnings and revenues with double-digit growth in Medical Devices, yet shares fall 5% pre-market.
Veeva Systems' Vault CRM Momentum Builds With Top Biopharma Adoptions
VEEV sees rising Vault CRM adoption among top biopharma firms, driven by new features, fueling customer migration and growth.
Should You Invest in Veeva ( VEEV ) Based on Bullish Wall Street Views?
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Why Veeva Systems ( VEEV ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veeva Systems ( VEEV ) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Veeva Systems (VEEV) stood at $275.89, denoting a -2.04% move from the preceding trading day.
Here is What to Know Beyond Why Veeva Systems Inc. ( VEEV ) is a Trending Stock
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI - ARK Genomic Revolution ETF ( BATS:ARKG )
On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. TEM and selling shares of Block Inc. XYZ. The trades were executed through the ARKG and ARKK ETFs.
Veeva Expands Market Reach Through Targeted Strategic Partnerships
VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.
Veeva Systems ( VEEV ) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV) reached $281 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
OPRX raised guidance after record Q1 EBITDA, but pharma budget shifts and margin mix pose new challenges ahead.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
$100 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 14.29% on an annualized basis producing an average annual return of 25.84%. Currently, Veeva Systems has a market capitalization of $45.98 billion.
VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
Close-Up International Appoints Jim Barone as Executive Vice President of Business Solutions to Continue Launch into US Pharma CRM Market
PRINCETON, N.J., July 01, 2025 ( GLOBE NEWSWIRE ) -- Close-Up International, a global leading provider of CRM and data technology solutions for the life sciences industry is pleased to announce the appointment of Jim Barone as Executive Vice President of Business Solutions.
3 Top Tech Stocks That Could Make You a Millionaire
Technological progress makes our lives more efficient, convenient, and comfortable. Hence, the technology sector has many promising growth stocks that can help you increase your wealth over the years or even decades.The key is to be patient and hold on to these stocks as their earnings and free ...
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global ...
Is It Worth Investing in Veeva ( VEEV ) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines
WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.
Veeva Systems Inc. ( VEEV ) is Attracting Investor Attention: Here is What You Should Know
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
